Latest Articles on Human Health
![clinical_collaboration_with_Mirati clinical_collaboration_with_Mirati](/sites/default/files/2023-03/AdobeStock_ResearchersWithFaceMasks2.jpg)
September 17, 2020
Boehringer Ingelheim and Mirati Therapeutics Announce Clinical Collaboration to Study BI 1701963, a SOS1::pan-KRAS Inhibitor in Combination with MRTX849, a KRAS G12C Selective Inhibitor
![Partnership-with-clicktherapeutics Partnership-with-clicktherapeutics](/sites/default/files/2023-03/BI%20CARMEN%20Press%20Release%20klein.jpg)
September 11, 2020